Literature DB >> 22034155

Characterization of primary Wilms tumor cultures as an in vitro model.

Jenny Wegert1, Sabrina Bausenwein, Sabine Roth, Norbert Graf, Eva Geissinger, Manfred Gessler.   

Abstract

Functional analysis of gene candidates and testing of novel therapeutics in Wilms tumors (WT) has been hampered by the lack of in vitro model systems. WT are characterized by a spectrum of histological appearances, but published cell lines are mostly derived from rare anaplastic variants or even non-WT. There has been some success in establishing primary cultures, but these are often poorly characterized or only derived from less frequent WT1 mutant tumors. We report the generation of a set of primary WT-cell cultures using a simple cultivation protocol. Our cultures could be established after preoperative chemotherapy and irrespective of histological subtypes or genetic alterations. The presence of tumor-specific genetic alterations validates these cultures as being tumor-derived. Genetic characterization is of utmost importance as some cultures with similar morphological appearance lacked such alterations and either represent clonal variants or normal cells. By immunohistochemistry, the cells are either epithelial or more mesenchymal, and the latter exhibiting a longer life span with 30 or more passages before undergoing senescence. This may be related to WT being embryonal tumors with a strong differentiation potential that may prevail in vitro. Telomeres progressively shorten with cultivation, but their length does not predict lifespan. hTERT transfection may partly allow establishment of immortalized lines, because 2/7 cultures avoid senescence even in later passages. Importantly, these cells can be efficiently manipulated by transfection, making them a useful model system for in vitro testing.
Copyright © 2011 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22034155     DOI: 10.1002/gcc.20936

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  7 in total

1.  A new method to monitor antigen-specific CD8+ T cells, avoiding additional target cells and the restriction to human leukocyte antigen haplotype.

Authors:  S Prommersberger; S Höfflin; B Schuler-Thurner; G Schuler; N Schaft; J Dörrie
Journal:  Gene Ther       Date:  2015-03-19       Impact factor: 5.250

2.  Molecular characterization of Wilms' tumor from a resource-constrained region of sub-Saharan Africa.

Authors:  Andrew J Murphy; Jason R Axt; Christian de Caestecker; Janene Pierce; Hernan Correa; Erin H Seeley; Richard M Caprioli; Mark W Newton; Mark P de Caestecker; Harold N Lovvorn
Journal:  Int J Cancer       Date:  2012-04-04       Impact factor: 7.396

3.  Retinoic acid pathway activity in Wilms tumors and characterization of biological responses in vitro.

Authors:  Jenny Wegert; Sabrina Bausenwein; Susanne Kneitz; Sabine Roth; Norbert Graf; Eva Geissinger; Manfred Gessler
Journal:  Mol Cancer       Date:  2011-11-08       Impact factor: 27.401

4.  An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity.

Authors:  Camilla Calandrini; Frans Schutgens; Rurika Oka; Thanasis Margaritis; Tito Candelli; Luka Mathijsen; Carola Ammerlaan; Ravian L van Ineveld; Sepide Derakhshan; Sanne de Haan; Emmy Dolman; Philip Lijnzaad; Lars Custers; Harry Begthel; Hindrik H D Kerstens; Lindy L Visser; Maarten Rookmaaker; Marianne Verhaar; Godelieve A M Tytgat; Patrick Kemmeren; Ronald R de Krijger; Reem Al-Saadi; Kathy Pritchard-Jones; Marcel Kool; Anne C Rios; Marry M van den Heuvel-Eibrink; Jan J Molenaar; Ruben van Boxtel; Frank C P Holstege; Hans Clevers; Jarno Drost
Journal:  Nat Commun       Date:  2020-03-11       Impact factor: 14.919

5.  Senescence Process in Primary Wilms' Tumor Cell Culture Induced by p53 Independent p21 Expression.

Authors:  Korkiat Theerakitthanakul; Jeerasak Khrueathong; Jirasak Kruatong; Potchanapond Graidist; Pritsana Raungrut; Kanita Kayasut; Surasak Sangkhathat
Journal:  J Cancer       Date:  2016-09-02       Impact factor: 4.207

Review 6.  Pediatric Tumors-Mediated Inhibitory Effect on NK Cells: The Case of Neuroblastoma and Wilms' Tumors.

Authors:  Andrea Pelosi; Piera Filomena Fiore; Sabina Di Matteo; Irene Veneziani; Ignazio Caruana; Stefan Ebert; Enrico Munari; Lorenzo Moretta; Enrico Maggi; Bruno Azzarone
Journal:  Cancers (Basel)       Date:  2021-05-14       Impact factor: 6.639

Review 7.  TRIM28 variants and Wilms' tumour predisposition.

Authors:  Janna A Hol; Illja J Diets; Ronald R de Krijger; Marry M van den Heuvel-Eibrink; Marjolijn Cj Jongmans; Roland P Kuiper
Journal:  J Pathol       Date:  2021-03-15       Impact factor: 7.996

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.